NCT01435122View on ClinicalTrials.gov

A Study of Axitinib in Advanced Carcinoid Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 25, 2011

Primary Completion Date

January 11, 2017

Study Completion Date

February 13, 2018

Conditions

Carcinoid Tumor

Interventions

DRUG

Axitinib

Axitinib Administration as outlined in Arm description

Trial Locations (2)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

94115

University of California San Francisco (UCSF), San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

National Comprehensive Cancer Network

NETWORK

collaborator

Pfizer

INDUSTRY

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT01435122 - A Study of Axitinib in Advanced Carcinoid Tumors | Biotech Hunter | Biotech Hunter